GOVX
GeoVax Labs, Inc.
-0.01 (-2.62%)0.39USD141K成交股數2.9M市值–本益比(近四季)–股價營收比-100.0%營收年增(近四季)–下次財報
內部人交易 SEC Form 4 · 董事、高階主管與持股 10% 以上股東 · 交易後兩個營業日內申報
買賣點與股價近一年
● 公開市場買進 · ● 公開市場賣出 · 空心 = 10b5-1 預設計畫(事先排程,不代表當下看法)。近一年,只畫 P / S 兩種代碼。
統計
| 近 90 天 買進筆數 · 金額 · 人數 | 0 · 0.00 · 0 |
|---|---|
| 近 90 天 賣出筆數 · 金額 · 人數 | 0 · 0.00 · 0 |
| 其中 10b5-1 計畫賣出 | 0 筆 |
| 近 180 天 買進 · 賣出金額 | 0.00 · 0.00 |
| 近 180 天 淨額 | 0.00 |
公開市場買進(P)是內部人自掏腰包,通常比賣出更有資訊含量 —— 賣出的理由很多(繳稅、分散、買房),買進的理由只有一個。
10b5-1 是事先排定的交易計畫,執行時點不反映當下看法。獲配股票(A)、繳稅扣股(F)、選擇權執行(M)是薪酬流程,不是意見。
| 交易日 | 申報日 | 申報人 | 職稱 | 代碼 | 股數 | 價格 | 金額 | 交易後持股 | 原件 |
|---|---|---|---|---|---|---|---|---|---|
| 2025-10-17 | 10-20 | SPENCER JOHN N JR | Director | P 公開市場買進 | 10.0K | 0.55 | 6K | 21.4K | SEC |
| 2025-08-07 | 08-08 | McKee Kelly T. Jr. | Chief Medical Officer | P 公開市場買進 | 1.1K | 0.67 | 741.69 | 3.5K | SEC |
| 2025-04-10 | 04-11 | SPENCER JOHN N JR | Director | P 公開市場買進 | 10.0K | 0.98 | 10K | 11.4K | SEC |
| 2025-04-10 | 04-10 | Sharkey John W. | VP, Business Development | P 公開市場買進 | 6.0K | 0.99 | 6K | 6.2K | SEC |
| 2025-04-01 | 04-01 | DODD DAVID A | President, CEO | P 公開市場買進 | 10.0K | 1.08 | 11K | 36.7K | SEC |
| 2025-03-31 | 03-31 | Reynolds Mark | CFO | P 公開市場買進 | 6.8K | 1.08 | 7K | 14.0K | SEC |
| 2024-08-09 | 08-12 | DODD DAVID A | President, CEO | P 公開市場買進 | 8.0K | 1.95 | 16K | 26.7K | SEC |
| 2024-02-22 | 02-22 | DODD DAVID A | President, CEO | P 公開市場買進 | 8.2K | 2.27 | 19K | 18.7K | SEC |
| 2024-02-21 | 02-22 | DODD DAVID A | President, CEO | P 公開市場買進 | 520 | 2.15 | 1K | 10.5K | SEC |
| 2024-02-07 | 02-07 | Reynolds Mark | CFO | P 公開市場買進 | 2.0K | 2.77 | 6K | 7.2K | SEC |
| 2023-12-22 | 12-26 | McKee Kelly T. Jr. | Chief Medical Officer | P 公開市場買進 | 6.9K | 0.36 | 2K | 35.8K | SEC |
| 2023-09-25 | 09-27 | McKee Kelly T. Jr. | Chief Medical Officer | P 公開市場買進 | 9.7K | 0.52 | 5K | 28.8K | SEC |
| 2023-08-25 | 08-28 | DODD DAVID A | President, CEO | P 公開市場買進 | 35.1K | 0.57 | 20K | 149K | SEC |
| 2023-08-18 | 08-21 | Reynolds Mark | CFO | P 公開市場買進 | 10.0K | 0.52 | 5K | 78.2K | SEC |
| 2023-04-24 | 04-25 | DODD DAVID A | President, CEO | P 公開市場買進 | 32.0K | 0.64 | 20K | 114K | SEC |
| 2023-04-20 | 04-21 | Reynolds Mark | CFO | P 公開市場買進 | 8.0K | 0.63 | 5K | 68.2K | SEC |
| 2022-09-21 | 09-23 | CHASE RANDAL D | Director | P 公開市場買進 | 10.0K | 1.10 | 11K | 36.6K | SEC |
| 2022-07-01 | 07-05 | Sharkey John W. | VP, Business Development | P 公開市場買進 | 1.0K | 0.82 | 820.00 | 2.9K | SEC |
| 2022-06-27 | 06-28 | McKee Kelly T. Jr. | Chief Medical Officer | P 公開市場買進 | 4.5K | 1.12 | 5K | 19.2K | SEC |
| 2022-06-21 | 06-22 | CHASE RANDAL D | Director | P 公開市場買進 | 10.0K | 1.21 | 12K | 26.6K | SEC |
| 2022-05-05 | 05-06 | McKee Kelly T. Jr. | Chief Medical Officer | P 公開市場買進 | 9.7K | 0.72 | 7K | 14.7K | SEC |
| 2022-05-04 | 05-05 | McKee Kelly T. Jr. | Chief Medical Officer | P 公開市場買進 | 5.0K | 0.71 | 4K | 5.0K | SEC |
| 2020-09-29 | 09-29 | SPENCER JOHN N JR | Director | P 公開市場買進 | 21.0K | 5.00 | 105K | 21.0K | SEC |
| 2020-09-29 | 09-29 | MCNALLY ROBERT T | Director | P 公開市場買進 | 53.9K | 5.00 | 270K | 53.9K | SEC |
| 2020-09-29 | 09-29 | DODD DAVID A | President, CEO | P 公開市場買進 | 81.9K | 5.00 | 409K | 81.9K | SEC |
| 2020-09-29 | 09-29 | Reynolds Mark | CFO | P 公開市場買進 | 60.2K | 5.00 | 301K | 60.2K | SEC |
| 2020-09-29 | 09-29 | CHASE RANDAL D | Director | P 公開市場買進 | 16.6K | 5.00 | 83K | 16.6K | SEC |
| 2020-09-29 | 09-29 | Kollintzas Dean G | Director | P 公開市場買進 | 12.0K | 5.00 | 60K | 12.0K | SEC |
| 2015-05-05 | 05-05 | CHASE RANDAL D | Director | P 公開市場買進 | 9.8K | 0.19 | 2K | 39.8K | SEC |
| 2015-05-05 | 05-05 | CHASE RANDAL D | Director | P 公開市場買進 | 200 | 0.19 | 38.00 | 40.0K | SEC |
| 2015-04-23 | 04-23 | Reynolds Mark | CFO | P 公開市場買進 | 10.0K | 0.18 | 2K | 66.0K | SEC |
| 2015-04-22 | 04-23 | Reynolds Mark | CFO | P 公開市場買進 | 10.0K | 0.17 | 2K | 56.0K | SEC |
| 2015-04-22 | 04-23 | Reynolds Mark | CFO | P 公開市場買進 | 10.0K | 0.17 | 2K | 46.0K | SEC |
| 2015-04-20 | 04-20 | CHASE RANDAL D | Director | P 公開市場買進 | 30.0K | 0.17 | 5K | 30.0K | SEC |
| 2015-04-20 | 04-20 | SPENCER JOHN N JR | Director | P 公開市場買進 | 18.0K | 0.17 | 3K | 46.6K | SEC |
| 2013-06-05 | 06-06 | ROBINSON HARRIET L | Chief Scientific Officer | G 贈與 | 27.5K | – | – | 1.2M | SEC |
| 2012-01-31 | 02-01 | Reynolds Mark | CFO | P 公開市場買進 | 15.0K | 0.67 | 10K | 36.0K | SEC |
| 2012-01-16 | 01-17 | Antebi Steven S. | Director | P 公開市場買進 | 30.0K | 0.67 | 20K | 30.0K | SEC |
| 2011-12-30 | 01-04 | MCNALLY ROBERT T | President/CEO | P 公開市場買進 | 29.9K | 0.67 | 20K | 29.9K | SEC |
| 2011-12-30 | 01-04 | ROBINSON HARRIET L | Chief Scientific Officer | P 公開市場買進 | 149K | 0.67 | 100K | 1.2M | SEC |
| 2011-12-30 | 01-04 | DODD DAVID A | Director | P 公開市場買進 | 112K | 0.67 | 75K | 128K | SEC |
| 2011-12-30 | 01-04 | Kollintzas Dean G | Director | P 公開市場買進 | 14.9K | 0.67 | 10K | 14.9K | SEC |
| 2011-12-30 | 01-04 | SPENCER JOHN N JR | Director | P 公開市場買進 | 14.9K | 0.67 | 10K | 28.6K | SEC |
| 2011-12-30 | 01-04 | Reynolds Mark | CFO | P 公開市場買進 | 15.0K | 0.67 | 10K | 21.0K | SEC |
| 2011-06-22 | 06-23 | ROBINSON HARRIET L | Chief Scientific Officer | G 贈與 | 7.4K | – | – | 1.1M | SEC |
| 2011-01-06 | 01-25 | ROBINSON HARRIET L | Chief Scientific Officer | G 贈與 | 9.7K | – | – | 1.1M | SEC |
| 2010-12-20 | 12-28 | ROBINSON HARRIET L | Chief Scientific Officer | G 贈與 | 33.3K | – | – | 1.1M | SEC |
| 2010-10-15 | 11-01 | MCNALLY ROBERT T | President & CEO | G 贈與 | 8.3K | – | – | 0 | SEC |
| 2010-07-02 | 07-06 | Reynolds Mark | Chief Financial Officer | P 公開市場買進 | 1.0K | 2.50 | 3K | 6.0K | SEC |
| 2010-06-11 | 06-14 | NEWMAN MARK J | VP, Research & Development | P 公開市場買進 | 1.0K | 3.25 | 3K | 1.0K | SEC |
| 2010-06-11 | 06-14 | NEWMAN MARK J | VP, Research & Development | P 公開市場買進 | 2.0K | 3.32 | 7K | 3.0K | SEC |
| 2010-06-10 | 06-14 | ROBINSON HARRIET L | Chief Scientific Officer | P 公開市場買進 | 2.1K | 3.35 | 7K | 1.1M | SEC |
| 2010-06-10 | 06-11 | ROBINSON HARRIET L | Chief Scientific Officer | P 公開市場買進 | 3.0K | 3.30 | 10K | 1.1M | SEC |
| 2010-06-10 | 06-11 | MCNALLY ROBERT T | President & CEO | P 公開市場買進 | 300 | 3.30 | 990.00 | 8.3K | SEC |
| 2010-06-09 | 06-10 | MCNALLY ROBERT T | President & CEO | P 公開市場買進 | 100 | 3.30 | 330.00 | 7.1K | SEC |
| 2010-06-09 | 06-10 | HILDEBRAND DONALD G | Director | P 公開市場買進 | 1.0K | 3.29 | 3K | 19.0K | SEC |
| 2010-06-09 | 06-10 | MCNALLY ROBERT T | President & CEO | P 公開市場買進 | 900 | 3.32 | 3K | 8.0K | SEC |
| 2010-06-09 | 06-10 | Reynolds Mark | Chief Financial Officer | P 公開市場買進 | 1.0K | 3.29 | 3K | 3.9K | SEC |
| 2010-06-09 | 06-10 | Reynolds Mark | Chief Financial Officer | P 公開市場買進 | 570 | 3.34 | 2K | 4.5K | SEC |
| 2010-06-09 | 06-10 | Reynolds Mark | Chief Financial Officer | P 公開市場買進 | 530 | 3.35 | 2K | 5.0K | SEC |
| 2010-06-08 | 06-10 | ROBINSON HARRIET L | Chief Scientific Officer | P 公開市場買進 | 400 | 3.23 | 1K | 1.1M | SEC |
| 2010-06-08 | 06-09 | DODD DAVID A | Director | P 公開市場買進 | 1.0K | 3.24 | 3K | 12.0K | SEC |
| 2010-06-08 | 06-09 | DODD DAVID A | Director | P 公開市場買進 | 3.7K | 3.25 | 12K | 15.7K | SEC |
| 2010-06-08 | 06-09 | MCNALLY ROBERT T | President & CEO | P 公開市場買進 | 1.0K | 3.25 | 3K | 7.0K | SEC |
| 2010-06-04 | 06-07 | ROBINSON HARRIET L | Chief Scientific Officer | P 公開市場買進 | 3.0K | 3.30 | 10K | 1.1M | SEC |
| 2010-06-03 | 06-07 | ROBINSON HARRIET L | Chief Scientific Officer | P 公開市場買進 | 500 | 3.31 | 2K | 1.1M | SEC |
| 2010-06-01 | 06-03 | MCNALLY ROBERT T | President & CEO | P 公開市場買進 | 1.0K | 3.49 | 3K | 6.0K | SEC |
| 2010-05-21 | 05-21 | MCNALLY ROBERT T | President & CEO | P 公開市場買進 | 1.0K | 4.20 | 4K | 5.0K | SEC |
| 2010-05-21 | 05-21 | DODD DAVID A | Director | P 公開市場買進 | 88 | 3.70 | 325.60 | 2.7K | SEC |
| 2010-05-21 | 05-21 | DODD DAVID A | Director | P 公開市場買進 | 5.4K | 3.99 | 21K | 8.1K | SEC |
| 2010-05-21 | 05-21 | DODD DAVID A | Director | P 公開市場買進 | 2.9K | 4.00 | 12K | 11.0K | SEC |
| 2010-05-21 | 05-21 | MCNALLY ROBERT T | President & CEO | P 公開市場買進 | 1.0K | 3.95 | 4K | 4.0K | SEC |
| 2010-05-21 | 05-21 | Tsolinas Peter M | Director | P 公開市場買進 | 2.0K | 4.10 | 8K | 432K | SEC |
| 2010-05-20 | 05-21 | Reynolds Mark | Chief Financial Officer | P 公開市場買進 | 796 | 3.60 | 3K | 2.9K | SEC |
| 2010-05-20 | 05-20 | DODD DAVID A | Director | P 公開市場買進 | 699 | 3.35 | 2K | 699 | SEC |
| 2010-05-20 | 05-20 | DODD DAVID A | Director | P 公開市場買進 | 500 | 3.39 | 2K | 1.2K | SEC |
| 2010-05-20 | 05-20 | DODD DAVID A | Director | P 公開市場買進 | 500 | 3.40 | 2K | 1.7K | SEC |
| 2010-05-20 | 05-20 | DODD DAVID A | Director | P 公開市場買進 | 459 | 3.55 | 2K | 2.2K | SEC |
| 2010-05-20 | 05-20 | DODD DAVID A | Director | P 公開市場買進 | 500 | 3.60 | 2K | 2.7K | SEC |
| 2010-05-20 | 05-20 | MCNALLY ROBERT T | President & CEO | P 公開市場買進 | 1.0K | 3.70 | 4K | 2.0K | SEC |
機構持股(13F) 管理規模 1 億美元以上的機構,每季末後 45 天內申報 · 最新 2026-06-30
前 25 大持有機構季末市值 · 與前一季股數比較
| 機構 | 持股 | 季末市值 | 股數季變化 | 動作 |
|---|---|---|---|---|
| JANE STREET GROUP, LLC | 315K | 400K | 新進 | 新進 |
| GEODE CAPITAL MANAGEMENT, LLC | 21.1K | 27K | 新進 | 新進 |
| TWO SIGMA SECURITIES, LLC | 10.7K | 14K | 新進 | 新進 |
| VANGUARD FIDUCIARY TRUST CO | 5.1K | 6K | 新進 | 新進 |
| Tower Research Capital LLC (TRC) | 3.5K | 4K | 新進 | 新進 |
| VANGUARD CAPITAL MANAGEMENT LLC | 3.2K | 4K | 新進 | 新進 |
| SBI Securities Co., Ltd. | 2.6K | 3K | 新進 | 新進 |
| MORGAN STANLEY | 2.0K | 3K | 新進 | 新進 |
| JONES FINANCIAL COMPANIES LLLP | 1.0K | 1K | 新進 | 新進 |
| UBS Group AG | 944 | 1K | 新進 | 新進 |
| BlackRock, Inc. | 842 | 1K | 新進 | 新進 |
| CITIGROUP INC | 230 | 292.00 | 新進 | 新進 |
| HRT FINANCIAL LP | 127K | 160.00 | 新進 | 新進 |
| WELLS FARGO & COMPANY/MN | 30 | 38.00 | 新進 | 新進 |
| DANSKE BANK A/S | 3 | 4.00 | 新進 | 新進 |
| FMR LLC | 1 | 1.00 | 新進 | 新進 |
| ROYAL BANK OF CANADA | 1 | 0.00 | 新進 | 新進 |
持有機構數近 12 季
每季 13F 申報中持有本股的機構家數;綠柱 = 比上季少。機構數是「有多少人在船上」,不是「買了多少」。
| 持有機構 · 季變化 | 17 +1 |
|---|---|
| 新進 / 出清 / 加碼 / 減碼 | 17 / 0 / 0 / 0 |
| 機構合計持股 · 佔流通股 | 493K · 6.7% |
| 合計季末市值 | 466K |
13F 只申報多頭部位(含可轉債與選擇權,選擇權這裡已排除),不申報放空,也不申報 1 億美元以下的機構。同一集團多個申報主體會各算一家。
放空餘額 FINRA 每月兩次(15 日與月底結算)· 最新 2026-08-31
空單佔流通股近 13 個月
FINRA 每月兩次結算的空單餘額佔流通股數的比例,近 13 個月。滑到柱子看股數與回補天數。
最新一期
| 空單股數 | 368K |
|---|---|
| 與上期比 | +101.6% |
| 佔流通股數 | 4.99% |
| 日均成交量 | 2.0M |
| 回補天數 | 1.0 天 |
空單佔比 10% 以上算高、20% 以上算很高(這是通行的說法,不是本站的判斷)。回補天數 = 空單 ÷ 日均量,天數愈長,空方要出場時愈容易推升股價。
放空餘額是「有人借股票賣掉還沒還」的存量,不代表看空的人正在加碼;避險基金做多空配對時也會產生空單。
| 結算日 | 空單股數 | 與上期比 | 佔流通股 | 日均量 | 回補天數 |
|---|---|---|---|---|---|
| 2026-08-31 | 368K | +101.6% | 4.99% | 2.0M | 1.0 |
| 2026-08-14 | 182K | +218.4% | 2.47% | 201K | 1.0 |
| 2026-07-31 | 57.3K | -61.9% | 0.78% | 220K | 1.0 |
| 2026-07-15 | 150K | +139.4% | 2.04% | 266K | 1.0 |
| 2026-06-30 | 62.9K | -76.9% | 0.85% | 436K | 1.0 |
| 2026-06-15 | 272K | -53.5% | 3.69% | 1.2M | 1.0 |
| 2026-05-29 | 584K | +24.1% | 7.93% | 31.1M | 1.0 |
| 2026-05-15 | 471K | +85.2% | 6.39% | 835K | 1.0 |
| 2026-04-30 | 254K | -8.4% | 3.45% | 129K | 2.0 |
| 2026-04-15 | 278K | +9.7% | 3.77% | 73.9K | 3.8 |
| 2026-03-31 | 253K | -4.7% | 3.43% | 69.9K | 3.6 |
| 2026-03-13 | 265K | +26.0% | 3.60% | 69.7K | 3.8 |
| 2026-02-27 | 211K | -22.7% | 2.86% | 161K | 1.3 |
| 2026-02-13 | 273K | -15.2% | 3.70% | 125K | 2.2 |
| 2026-01-30 | 322K | +112.3% | 4.36% | 202K | 1.6 |
| 2026-01-15 | 152K | -90.0% | 2.06% | 211K | 1.0 |
| 2025-12-31 | 1.5M | -51.5% | 20.55% | 6.2M | 1.0 |
| 2025-12-15 | 3.1M | +3.3% | 42.39% | 646K | 4.8 |
| 2025-11-28 | 3.0M | +0.3% | 41.06% | 488K | 6.2 |
| 2025-11-14 | 3.0M | -3.9% | 40.93% | 516K | 5.9 |
| 2025-10-31 | 3.1M | +1.0% | 42.59% | 777K | 4.0 |
| 2025-10-15 | 3.1M | -16.0% | 42.16% | 1.2M | 2.6 |
| 2025-09-30 | 3.7M | -2.5% | 50.18% | 1.1M | 3.3 |
| 2025-09-15 | 3.8M | -6.8% | 51.49% | 526K | 7.2 |
| 2025-08-29 | 4.1M | +24.4% | 55.22% | 817K | 5.0 |
| 2025-08-15 | 3.3M | -12.3% | 44.39% | 701K | 4.7 |